Yerxa Benjamin R
- SEC CIK
- 0001145910
In the past year, 2 open-market sale filings worth $61.2K and no purchases.
Current role at each company
- IRD Opus Genetics, Inc.Presidentas of Jul 27, 2026
- CLSD Clearside Biomedical, Inc.Directoras of Jun 21, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $61.2K
- 2 filings
- Net
- −$61.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Yerxa Benjamin R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IRD Opus Genetics, Inc.
President3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 (view filing) | Nov 21 | 4 days | Yerxa Benjamin RPresident | PPurchase | +10.0K | $0.98 | +$9.80K | +3.0%342.8K after | |
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Yerxa Benjamin RPresident | SSale | −7.47K | $5.24 | −$39.1K | −1.0%711.5K after | |
| Jul 27, 2026 (view filing)4:08 PM ET | Jul 23 | 4 days | Yerxa Benjamin RPresident | SSale | −7.43K | $2.97 | −$22.1K | −1.0%704.1K after |
CLSD Clearside Biomedical, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2024 (view filing) | May 15 | Same day | Yerxa Benjamin RDirector | PPurchase | +7.81K | $1.31 | +$10.2K | +77.0%18.0K after |